-
Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): A multicentre randomised, double blind, placebo controlled trial (PEARL trial)
de Wit, K., Schaapman, J. J., Nevens, F., Verbeek, J., Coenen, S., Cuperus, F. J. C., Kramer, M., Tjwa, E. T. T. L., Mostafavi, N., DIjkgraaf, M. G. W., van Delden, O. M., Beuers, U. H. W., Coenraad, M. J. & Takkenberg, R. B., 28 Dec 2020, In: BMJ open gastroenterology. 7, 1, e000531.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
